Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes In Temporary Equity And Stockholders' Deficiency (Unaudited)

v3.21.1
Condensed Consolidated Statement of Changes In Temporary Equity And Stockholders' Deficiency (Unaudited) - USD ($)
Series B Convertible Redeemable Preferred Stock [Member]
Common Stock [Member]
Treasury Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Gaucho Group Holdings Stockholder's Deficiency [Member]
Noncontrolling Interest [Member]
Total
Balance at Dec. 31, 2019 $ 9,026,824                
Balance, shares at Dec. 31, 2019 902,670                
Balance at Dec. 31, 2019   $ 40,215 $ (46,355) $ 91,238,518 $ (12,399,833) $ (87,886,307) $ (9,053,762) $ 26,364 $ (9,027,398)
Balance, shares at Dec. 31, 2019   4,021,470 3,369            
Options and warrants       103,581 103,581   103,581
Net loss           (1,252,847) (1,252,847) (42,645) (1,295,492)
Other comprehensive income         128,051 128,051 128,051
Balance at Mar. 31, 2020 $ 9,026,824                
Balance, shares at Mar. 31, 2020 902,670                
Balance at Mar. 31, 2020   $ 40,215 $ (46,355) 91,342,099 (12,271,782) (89,139,154) (10,074,977) (16,281) $ (10,091,258)
Balance, shares at Mar. 31, 2020   4,021,470 3,369            
Balance at Dec. 31, 2020 $ 9,010,824                
Balance, shares at Dec. 31, 2020 901,070               901,070
Balance at Dec. 31, 2020   $ 52,344 $ (46,355) 96,951,440 (11,932,801) (93,534,828) (8,510,200) (106,798) $ (8,616,998)
Balance, shares at Dec. 31, 2020   5,234,406 3,369            
Options and warrants       101,453     101,453 67,196 168,649
Common stock and warrants issued for cash, in public offering, net of offering costs [1]   $ 13,333   6,589,008     6,602,341   6,602,341
Common stock and warrants issued for cash, in public offering, net of offering costs, shares [1]   1,333,334              
Common stock issued for cash   $ 732   438,268     439,000   439,000
Common stock issued for cash, shares   73,167              
Common stock and warrants issued to underwriter in public offering       297,963     297,963   297,963
Common stock and warrants issued upon exchange of debt and accrued interest   $ 2,370   1,419,698     1,422,068   1,422,068
Common stock and warrants issued upon exchange of debt and accrued interest, shares   237,012              
Common stock issued upon conversion of Series B Convertible Preferred Stock $ (9,010,824) $ 6,007   9,004,817     9,010,824   9,010,824
Common stock issued upon conversion of Series B Convertible Preferred Stock, shares (901,070) 600,713              
Effect of reverse stock split
Effect of reverse stock split, shares 495              
Net loss           (1,112,851) (1,112,851) (27,509) (1,140,360)
Other comprehensive income         98,980   98,980   $ 98,980
Balance, shares at Mar. 31, 2021                 0
Balance at Mar. 31, 2021   $ 74,786 $ (46,355) $ 114,802,647 $ (11,833,821) $ (94,647,679) $ 8,349,578 $ (67,111) $ 8,282,467
Balance, shares at Mar. 31, 2021   7,479,127 3,369            
[1] Includes gross proceeds of $8,002,004, less offering costs of $1,399,663 ($1,034,684 of cash and $364,979 of non-cash).